Medicine guide

TAKHZYRO

As listed in the register: TAKHZYRO

300 mg · solution

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Lanadelumab
Made by
Takeda Canada Inc

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupBlood, clotting and anaemiaB06AC05

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byTakeda Canada Inc
Active substanceLanadelumab
Used inBlood, clotting and anaemia
Strength300 mg
Formsolution
ClassificationB06AC05 · Blood, clotting and anaemia
Routesubcutaneous
Dispensing (as stated by the register)SCHEDULE D · PRESCRIPTION
StatusMarketed
MarketedYes, according to the register
DIN02505614
DPD drug code99498

Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician

Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.

Other strengths and forms

4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.